TODAY: Buchholz won’t undergo surgery, telling Buchanan (Twitter link) and other reporters that he will receive a PRP injection. The right-hander expects to be ready to pitch by Spring Training.
YESTERDAY: Diamondbacks righty Clay Buchholz will not return to the club in 2018, skipper Torey Lovullo tells reporters including Zach Buchanan of The Athletic (Twitter links). Buchholz has been diagnosed with a flexor mass strain in his right elbow.
While the D-Backs won tonight, their postseason hopes are fading regardless of the status of Buchholz. Still, it’s another blow to a team that has collapsed late in the season.
The news is a bigger problem, perhaps, for the veteran hurler. He has had plenty of arm troubles in the past, which helps explain how he ended up in Arizona on a minors deal. Buchholz originally signed this year with the Royals but was allowed to depart rather than being added to the MLB roster.
The Snakes were rewarded handsomely for the decision to bring Buchholz in, even if he won’t be able to finish out the season. He not only filled 98 1/3 innings, but allowed just 2.01 earned runs per nine along the way while recording 81 strikeouts against 22 walks.
That showing seemed to set the veteran up for a more successful return to the open market. There were some issues, to be sure, including the fact that he’s averaging about two miles per hour less on his fastball than he did in his most recent full seasons. But that didn’t stop Buchholz from posting a 9.7% swinging-strike rate that raised his career average.
Still-unknown details of the injury certainly remain the key to this story, as the true severity of the injury isn’t really clear. It’s certainly possible that Buchholz will be able to get back up to full strength with some offseason rest and rehab. Regardless, it’s a disappointing way for an otherwise encouraging campaign to wrap up.